Sward Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 122.01%
(FY 2021)
- Profit -52.00%
(FY 2021)
- Ebitda -7.26%
(FY 2021)
- Net Worth 7.36%
(FY 2021)
- Total Assets 100.63%
(FY 2021)
About Sward Formulations
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kewal Dakalia and Dinesh Dakalia serve as directors at the Company.
- CIN/LLPIN
U24100MH2018PTC315055
- Company No.
315055
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2018
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationNavi Mumbai, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sward Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kewal Dakalia  | Director | 26-Apr-2021 | Current |
| Dinesh Dakalia | Director | 29-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Sward Formulations.
Sward Formulations Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 122.01% increase. The company also saw a substantial fall in profitability, with a 52% decrease in profit. The company's net worth moved up by a moderate rise of 7.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sward Formulations?
Unlock access to Sward Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Navmantra Agro Products Private LimitedActive 4 years 17 daysKewal Dakalia and Dinesh Dakalia are mutual person
- Navnidhi Super Infracon Private LimitedActive 14 years 3 months
Kewal Dakalia and Dinesh Dakalia are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sward Formulations?
Unlock and access historical data on people associated with Sward Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sward Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sward Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
